CGM-based parameters for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-naive patients with type 2 diabetes

被引：0
|
作者：
Lingvay, I. [1 ]
Bang, R. Beck [2 ]
Liu, L. [2 ]
Mader, J. [3 ]
Pettus, J. [4 ]
Wagner, L. [2 ]
Mathieu, C. [5 ]
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] Novo Nordisk S, Soborg, Denmark
[3] Med Univ sity Graz, Graz, Austria
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Univ Leuven, Leuven, Belgium
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
508
引用
收藏
页码：265 / 266
页数：2
相关论文
共 50 条
  • [1] CGM-based measurements for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-treated patients with type 2 diabetes: a post hoc analysis
    Bajaj, H. S.
    Bang, R. Beck
    Gowda, A.
    Liu, L.
    Senior, P.
    Bergenstal, R.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 266 - 266
  • [2] CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
    Bergenstal, R.
    Watt, S. Kehlet
    Matos, A. S. A.
    Lingvay, I.
    Mader, J. K.
    Nishida, T.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S397
  • [3] CGM Parameters for once a week Administration of Insulin icodec versus daily Administration of Insulin glargine U100 in insulin-naive Female Patients with Type 2 Diabetes
    Mader, Julia K.
    Lingvay, Ildiko
    Beck, Bang R.
    Koefoe, Mette M.
    Pettus, Jeremy
    Wagner, Lily
    Mathieu, Chantal
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 200 - 201
  • [4] CGM Outcomes and Hypoglycemia Duration with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 in Insulin-Naive T2D-ONWARDS 1 Exploratory Analysis
    Bergenstal, Richard M.
    Watt, Sara K.
    Matos, Ana Laura S. A.
    Lingvay, Ildiko
    Mader, Julia K.
    Nishida, Tomoyuki
    Rosenstock, Julio
    [J]. DIABETES, 2023, 72
  • [5] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
  • [6] Similar hypoglycaemia duration with once-weekly insulin icodec vs insulin glargine U100 in insulin naive or experienced patients with type 2 diabetes
    Silver, R.
    Asong, M.
    Begtrup, K.
    Heller, S. R.
    Liu, L.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 73 - 73
  • [7] CGM-Based Measurements for Once-Weekly Insulin Icodec vs. Once Daily Insulin Glargine U100 in Insulin Treated Patients with T2D: A Post-hoc Analysis
    Bajaj, Harpreet S.
    Bang, Rikke Beck
    Gowda, Amoolya
    Koefoed, Mette M.
    Senior, Peter A.
    Bergenstal, Richard M.
    [J]. DIABETES, 2021, 70
  • [8] CGM-Derived Parameters for Once-Weekly Insulin Icodec vs. Once Daily Insulin Glargine U100 in Insulin Na ve Patients with T2D
    Lingvay, Ildiko
    Bang, Rikke Beck
    Koefoed, Mette M.
    Mader, Julia K.
    Pettus, Jeremy
    Wagner, Lily
    Mathieu, Chantal
    [J]. DIABETES, 2021, 70
  • [9] Once-Weekly Basal Insulin Icodec Offers Comparable Efficacy and Safety vs. Once-Daily Insulin Glargine U100 in Insulin-Naive Patients with T2D Inadequately Controlled on OADS
    Rosenstock, Julio
    Kjaersgaard, Maiken I. S.
    Moller, Daniel
    Hansen, Melissa Voigt
    Goldenberg, Ronald
    [J]. DIABETES, 2020, 69
  • [10] Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes The ONWARDS 3 Randomized Clinical Trial
    Lingvay, Ildiko
    Asong, Marisse
    Desouza, Cyrus
    Gourdy, Pierre
    Kar, Soumitra
    Vianna, Andre
    Vilsboll, Tina
    Vinther, Siri
    Mu, Yiming
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (03): : 228 - 237
12345